Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China · Delayed Price · Currency is CNY 10.26
+0.77 (8.11%)
Nov 2, 2026, 3:04 PM CST
SHE:300439 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 387.9 | 657.57 | 728.64 | 958.88 | 806.41 | 666.31 |
Short-Term Investments | - | 54.38 | 10.12 | - | - | - |
Trading Asset Securities | 624.5 | 265.43 | 161.08 | 6 | 80.17 | 100.7 |
Cash & Short-Term Investments | 1,012 | 977.37 | 899.84 | 964.88 | 886.58 | 767.01 |
Cash Growth | 12.94% | 8.62% | -6.74% | 8.83% | 15.59% | 133.70% |
Accounts Receivable | 650.3 | 581.6 | 557.16 | 569.92 | 816.36 | 827.94 |
Other Receivables | 9.16 | 18.3 | 15.56 | 36.32 | 75.69 | 45.9 |
Receivables | 659.46 | 599.9 | 572.72 | 606.24 | 892.05 | 873.84 |
Inventory | 268.15 | 231.07 | 286.01 | 259.01 | 218.03 | 211.39 |
Other Current Assets | 78.9 | 84.33 | 65.63 | 69.03 | 74.88 | 157.7 |
Total Current Assets | 2,019 | 1,893 | 1,824 | 1,899 | 2,072 | 2,010 |
Property, Plant & Equipment | 1,124 | 1,210 | 1,416 | 1,178 | 1,065 | 1,048 |
Long-Term Investments | 168.67 | 163.35 | 190.73 | 160.94 | 162.7 | 184.38 |
Other Intangible Assets | 111.75 | 126.89 | 135.43 | 127.85 | 120.19 | 148.37 |
Long-Term Deferred Tax Assets | 53.13 | 52.77 | 40.75 | 35.53 | 25.55 | 41.11 |
Long-Term Deferred Charges | 25.34 | 29.75 | 39.82 | 34.34 | 18.6 | 35.24 |
Other Long-Term Assets | 220.47 | 178.18 | 57.94 | 53.05 | 119.82 | 125.81 |
Total Assets | 3,723 | 3,654 | 3,705 | 3,489 | 3,584 | 3,593 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 336.45 | 356.41 | 369.41 | 333.46 | 374.26 | 331.34 |
Accrued Expenses | 62.25 | 86.22 | 102.97 | 109.57 | 123.02 | 129.15 |
Short-Term Debt | 60 | 20 | 30.02 | 50.05 | 217.76 | 340.22 |
Current Portion of Long-Term Debt | 12.12 | - | - | 7.04 | 63.12 | 52.12 |
Current Portion of Leases | - | 11.48 | 15.79 | 12.48 | 16.75 | 18.86 |
Current Income Taxes Payable | 14.01 | 6.06 | 9.62 | 15.91 | 10.8 | 15.41 |
Current Unearned Revenue | 50.95 | 55.85 | 63.78 | 88.27 | 75.45 | 37.93 |
Other Current Liabilities | 82.55 | 87.97 | 75.85 | 82.34 | 100.13 | 136.17 |
Total Current Liabilities | 618.33 | 623.99 | 667.44 | 699.13 | 981.3 | 1,061 |
Long-Term Debt | - | - | - | - | 7.04 | 45.03 |
Long-Term Leases | 19.76 | 27.74 | 37.11 | 23.6 | 26.97 | 25.64 |
Long-Term Unearned Revenue | 25.89 | 25.96 | 17.02 | 9.9 | 2.32 | 9.39 |
Long-Term Deferred Tax Liabilities | 22.85 | 27 | 46.28 | 48.42 | 34.98 | 61.19 |
Other Long-Term Liabilities | - | 1.37 | 3.8 | 1.45 | 11.62 | - |
Total Liabilities | 686.83 | 706.06 | 771.65 | 782.49 | 1,064 | 1,202 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 383.84 | 384.32 | 383.95 | 383 | 383 | 383 |
Additional Paid-In Capital | 1,119 | 1,121 | 1,120 | 1,109 | 1,117 | 1,117 |
Retained Earnings | 1,555 | 1,470 | 1,458 | 1,252 | 1,035 | 872.85 |
Treasury Stock | - | -2.91 | -5.82 | - | - | - |
Comprehensive Income & Other | -17.15 | -17.95 | -16.94 | -29.14 | -24.69 | -25.59 |
Total Common Equity | 3,040 | 2,954 | 2,940 | 2,715 | 2,510 | 2,347 |
Minority Interest | -4.31 | -6.58 | -6.36 | -8.24 | 9.38 | 43.72 |
Shareholders' Equity | 3,036 | 2,948 | 2,933 | 2,707 | 2,519 | 2,391 |
Total Liabilities & Equity | 3,723 | 3,654 | 3,705 | 3,489 | 3,584 | 3,593 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 91.88 | 59.22 | 82.92 | 93.17 | 331.64 | 481.87 |
Net Cash (Debt) | 920.52 | 918.15 | 816.92 | 871.71 | 554.94 | 285.14 |
Net Cash Growth | 8.12% | 12.39% | -6.29% | 57.08% | 94.62% | - |
Net Cash Per Share | 2.33 | 2.32 | 2.12 | 2.28 | 1.45 | 0.76 |
Filing Date Shares Outstanding | 383.79 | 384.32 | 383.95 | 383.95 | 383 | 383 |
Total Common Shares Outstanding | 383.79 | 384.32 | 383.95 | 383 | 383 | 383 |
Working Capital | 1,401 | 1,269 | 1,157 | 1,200 | 1,090 | 948.74 |
Book Value Per Share | 7.92 | 7.69 | 7.66 | 7.09 | 6.55 | 6.13 |
Tangible Book Value | 2,928 | 2,827 | 2,804 | 2,587 | 2,390 | 2,199 |
Tangible Book Value Per Share | 7.63 | 7.36 | 7.30 | 6.75 | 6.24 | 5.74 |
Buildings | - | 921.35 | 1,085 | 749.23 | 544.4 | 544.18 |
Machinery | - | 851.79 | 902.18 | 912.39 | 936.77 | 936.19 |
Construction In Progress | - | 20.82 | 11.99 | 160.5 | 189.8 | 141.11 |